Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d’Athérosclérose (NSFA)-Reference-Cited by-同舟云学术

Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d’Athérosclérose (NSFA)

Published:2021-12 Issue:12 Volume:114 Page:828-847
ISSN:1875-2136
Container-title:Archives of Cardiovascular Diseases
language:en
Short-container-title:Archives of Cardiovascular Diseases

Author:

Durlach Vincent,Bonnefont-Rousselot Dominique,Boccara Franck,Varret Mathilde^ORCID,Di-Filippo Charcosset Mathilde^ORCID,Cariou Bertrand,Valero René,Charriere Sybil,Farnier Michel,Morange Pierre E.^ORCID,Meilhac Olivier,Lambert Gilles^ORCID,Moulin Philippe,Gillery Philippe^ORCID,Beliard-Lasserre Sophie,Bruckert Eric,Carrié Alain,Ferrières Jean,Collet Xavier,Chapman M. John,Anglés-Cano Eduardo^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference186 articles.

1. A new serum type system in Man – the Lp System;Berg;Acta Pathol Microbiol Scand,1963

2. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen;Eaton;Proc Natl Acad Sci U S A,1987

3. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen;McLean;Nature,1987

4. Human genetics and the causal role of lipoprotein(a) for various diseases;Kronenberg;Cardiovasc Drugs Ther,2016

5. Association of LPA variants with risk of coronary disease and the implications for lipoprotein(a)-lowering therapies: a Mendelian Randomization Analysis;Burgess;JAMA Cardiol,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. La phospholipase A2 associée aux lipoprotéines (Lp-PLA2) : biomarqueur pertinent et cible thérapeutique ?;Annales Pharmaceutiques Françaises;2024-09

2. Lipoprotéine (a) : faut-il la doser chez les patients diabétiques ?;Médecine des Maladies Métaboliques;2024-09

3. Lipoprotein(a) and cardiovascular disease;The Lancet;2024-09

4. Lipoprotein(a): Don’t forget about secondary prevention;European Journal of Preventive Cardiology;2024-08-21

5. Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid Profiles;Clinical Chemistry;2024-04-22